SCHEMBL20746299

SCHEMBL20746299

CCCCC(CCCC)[SiH](C)Oc1ccc(-c2nccc(C(=O)OC)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ MAPT P10636 5/20 0.38
▸ NPC1 O15118 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ ALPL P05186 1/20 0.36
▸ PLA2G2A P14555 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ACACB O00763 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25002892 0.82 NPC1 (0.52) KMT2ARAB9ASMN1; SMN2MAPTNPC1
SCHEMBL25002912 0.77 PLA2G2A (0.48) KMT2ARAB9ASMN1; SMN2MAPTNPC1
SCHEMBL25002930 0.77 RAB9A (0.49) KMT2ARAB9ASMN1; SMN2MAPTNPC1
SCHEMBL25002922 0.75 KMT2A (0.56) KMT2ASMN1; SMN2MAPTNPC1KDM4E
SCHEMBL25002900 0.74 KMT2A (0.51) KMT2ARAB9ASMN1; SMN2MAPTNPC1
SCHEMBL25002901 0.71 ADORA3 (0.49) KMT2ARAB9ASMN1; SMN2MAPTNPC1
SCHEMBL25002890 0.70 MAP4K4 (0.51) KMT2ARAB9ASMN1; SMN2MAPTNPC1
SCHEMBL22027749 0.70 KMT2A (0.42) KMT2ARAB9ASMN1; SMN2MAPTNPC1
SCHEMBL3140118 0.70 SCN9A (0.57) KMT2AMAPTMEN1SCN9A
SCHEMBL14741986 0.70 MAPT (0.48) KMT2ASMN1; SMN2MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3668502-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE AbbVie Inc. (US) 2020-06-24 — — EP disclosed
WO-2019035927-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC. (US) 2019-02-21 — — WO disclosed
Send feedback